Loading the section…
The price of Aytu BioPharma, Inc. (AYTU) on October 9, 2026 is 2.03 USD, −0.98% on the day. Over 52 weeks the stock traded between 1.80 USD and 3.07 USD; the price now sits 18% of the way up that range. Over the past year the price changed by −14.35%. Market capitalization is 12.75 million USD, rank 300 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): −13.25 %
Aytu BioPharma, Inc. trades on Nasdaq under the ticker AYTU. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks AYTU has traded between 1.80 $ and 3.07 $. As of 9 October 2026 the price stood 18.11 % of the way from the 52-week low to the high.
Over one year AYTU shares fell 14.35 %; over six months they fell 20.39 %. Volatility over 90 days is 39.99 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss for the latest fiscal year, so a price-to-earnings ratio is not calculated. Price to sales is 0.2, below the sector median of 4.0. Price to book is 0.4, below the sector median of 2.5. Calculated from reports for the period ending 30 June 2025.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 2.04 | 2.07 | 2.02 | 2.03 | 10,500 |
| 8 October 2026 | 2.05 | 2.09 | 2.05 | 2.05 | 5,600 |
| 7 October 2026 | 2.04 | 2.10 | 2.03 | 2.05 | 5,700 |
| 6 October 2026 | 2.05 | 2.09 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 30 June 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:7900 E. UNION AVENUE SUITE 920, DENVER, CO, 80237, US
Aytu BioPharma, Inc. reported revenue of 57M $ and a net loss of 14M $ for the latest fiscal year. Revenue changed by −14.04 % year over year. Market capitalisation is 13M $.
AYTU has a return on equity of −38.59 %, above the sector median of −41.68 %. Return on assets is −12.14 %, above the sector median of −32.11 %. Operating margin is −26.79 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 2.02 |
| 2.05 |
| 21,600 |
| 5 October 2026 | 2.05 | 2.15 | 2.04 | 2.04 | 63,900 |
| 2 October 2026 | 2.08 | 2.15 | 2.06 | 2.07 | 15,800 |
| 1 October 2026 | 2.15 | 2.15 | 2.04 | 2.09 | 29,900 |
| 30 September 2026 | 2.18 | 2.20 | 2.13 | 2.14 | 67,700 |
| 29 September 2026 | 2.19 | 2.20 | 2.15 | 2.20 | 37,100 |
| 28 September 2026 | 2.23 | 2.24 | 2.17 | 2.17 | 16,400 |
| 25 September 2026 | 2.28 | 2.29 | 2.21 | 2.28 | 28,200 |
| 24 September 2026 | 2.23 | 2.34 | 2.21 | 2.31 | 70,000 |
| 23 September 2026 | 2.34 | 2.35 | 2.12 | 2.28 | 187,900 |
| 22 September 2026 | 2.18 | 2.33 | 2.14 | 2.23 | 274,100 |
| 21 September 2026 | 2.20 | 2.20 | 2.10 | 2.13 | 49,400 |
| 18 September 2026 | 2.00 | 2.17 | 2.00 | 2.12 | 54,600 |
| 17 September 2026 | 2.15 | 2.15 | 1.97 | 2.00 | 7,100 |
| 16 September 2026 | 1.89 | 2.01 | 1.89 | 1.97 | 17,000 |
| 15 September 2026 | 2.00 | 2.07 | 1.98 | 1.99 | 37,000 |
| 14 September 2026 | 2.09 | 2.10 | 1.95 | 2.00 | 28,500 |